title: Unbiased and automated identification of a circulating tumour cell definition that associates with overall survival.
abstract: Circulating tumour cells (CTC) in patients with metastatic carcinomas are associated with poor survival and can be used to guide therapy. Classification of CTC however remains subjective, as they are morphologically heterogeneous. We acquired digital images, using the CellSearch™ system, from blood of 185 castration resistant prostate cancer (CRPC) patients and 68 healthy subjects to define CTC by computer algorithms. Patient survival data was used as the training parameter for the computer to define CTC. The computer-generated CTC definition was validated on a separate CRPC dataset comprising 100 patients. The optimal definition of the computer defined CTC (aCTC) was stricter as compared to the manual CellSearch CTC (mCTC) definition and as a consequence aCTC were less frequent. The computer-generated CTC definition resulted in hazard ratios (HRs) of 2.8 for baseline and 3.9 for follow-up samples, which is comparable to the mCTC definition (baseline HR 2.9, follow-up HR 4.5). Validation resulted in HRs at baseline/follow-up of 3.9/5.4 for computer and 4.8/5.8 for manual definitions. In conclusion, we have defined and validated CTC by clinical outcome using a perfectly reproducing automated algorithm.
authors.affiliation: Medical Cell BioPhysics group, MIRA Institute, University of Twente, Enschede, The Netherlands.
authors.forename: Sjoerd T
authors.initials: ST
authors.lastname: Ligthart
authors.forename: Frank A W
authors.initials: FA
authors.lastname: Coumans
authors.forename: Gerhardt
authors.initials: G
authors.lastname: Attard
authors.forename: Amy Mulick
authors.initials: AM
authors.lastname: Cassidy
authors.forename: Johann S
authors.initials: JS
authors.lastname: de Bono
authors.forename: Leon W M M
authors.initials: LW
authors.lastname: Terstappen
mesh_terms: D000465:Algorithms; D001331:Automation; D016022:Case-Control Studies; D003936:Diagnosis, Computer-Assisted; D006801:Humans; D008297:Male; D009360:Neoplastic Cells, Circulating / Q000145:classification* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000473:pathology; D015996:Survival Rate
references.citation: Clin Cancer Res. 2006 Nov 1;12(21):6403-9
references.pmid: 17085652
references.citation: Nature. 2010 Sep 30;467(7315):543-9
references.pmid: 20882008
references.citation: Cytometry B Clin Cytom. 2011 Mar;80(2):112-8
references.pmid: 21337491
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6897-904
references.pmid: 15501967
references.citation: J Histochem Cytochem. 1977 Jul;25(7):741-53
references.pmid: 70454
references.citation: Lancet Oncol. 2009 Mar;10(3):233-9
references.pmid: 19213602
references.citation: Ann Oncol. 2009 Jan;20(1):27-33
references.pmid: 18695026
references.citation: Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4218-24
references.pmid: 16857794
references.citation: J Clin Oncol. 2009 Aug 10;27(23):3742-8
references.pmid: 19470933
references.citation: J Clin Oncol. 2010 Mar 20;28(9):1489-95
references.pmid: 20159823
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4589-94
references.pmid: 9539782
references.citation: Curr Opin Genet Dev. 2011 Feb;21(1):50-8
references.pmid: 21112767
references.citation: N Engl J Med. 2004 Aug 19;351(8):781-91
references.pmid: 15317891
references.citation: Clin Cancer Res. 2008 Oct 1;14(19):6302-9
references.pmid: 18829513
references.citation: Cytometry A. 2007 Mar;71(3):154-62
references.pmid: 17200956
references.citation: J Clin Oncol. 1999 Nov;17(11):3461-7
references.pmid: 10550143
references.citation: J Clin Oncol. 2008 Jul 1;26(19):3213-21
references.pmid: 18591556
references.citation: Ann Oncol. 2010 Sep;21(9):1851-1857
references.pmid: 20147742
references.citation: J Clin Oncol. 2008 Oct 1;26(28):4563-71
references.pmid: 18645193